Research graph
References from KDmarkers: A biomarker database for investigating epigenetic methylation and gene expression levels in Kawasaki disease. Local targets link to admitted publications; unresolved targets remain external evidence.
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan
10.1542/peds.54.3.271 · 1974 · External reference
Preventing coronary artery lesions in Kawasaki disease
10.1016/j.bj.2017.04.002 · 2017 · External reference
Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array
10.1002/art.38976 · 2015 · External reference
Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease
2016 · External reference
The human blood DNA methylome identifies crucial role of β)catenin in the pathogenesis of Kawasaki disease
10.18632/oncotarget.25305 · 2018 · External reference
Increase expression of CD177 in Kawasaki disease
2019 · External reference
Identifying genetic hypomethylation and upregulation of toll-like receptors in Kawasaki disease
10.18632/oncotarget.14497 · 2017 · External reference
Epigenetic regulation of macrophage marker expression profiles in Kawasaki disease
10.3389/fped.2020.00129 · 2020 · External reference
Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration
2018 · External reference
Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease
10.18632/oncotarget.19650 · 2017 · External reference
10.1038/nrg3273
10.1038/nrg3273 · External reference
Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease
10.18632/oncotarget.24851 · 2018 · External reference
Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association
10.1161/cir.0000000000000484 · 2017 · External reference
HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease
10.1016/j.yjmcc.2018.02.017 · 2018 · External reference
Inferring functional transcription factor-gene binding pairs by integrating transcription factor binding data with transcription factor knockout data
2013 · External reference
Transcription factor regulatory modules provide the molecular mechanisms for functional redundancy observed among transcription factors in yeast
2019 · External reference
Cancer DEIso: an integrative analysis platform for investigating differentially expressed gene-level and isoform-level human cancer markers, Computational and Structural
2021 · External reference
Human IRES Atlas: an integrative platform for studying IRES-driven translational regulation in humans
2021 · External reference
10.1093/database/baw109
10.1093/database/baw109 · External reference
10.1093/nar/gkn923
10.1093/nar/gkn923 · External reference
10.1038/nri3682
10.1038/nri3682 · External reference
10.3390/cells10071720
10.3390/cells10071720 · External reference
10.1371/journal.pone.0061975
10.1371/journal.pone.0061975 · External reference
Alternate transcription of the Toll-like receptor signaling cascade
10.1186/gb-2006-7-2-r10 · 2006 · External reference
10.1016/j.micinf.2007.06.009
10.1016/j.micinf.2007.06.009 · External reference
10.4049/jimmunol.165.12.6682
10.4049/jimmunol.165.12.6682 · External reference
10.1086/374755
10.1086/374755 · External reference
10.4049/jimmunol.176.5.3010
10.4049/jimmunol.176.5.3010 · External reference
10.4049/jimmunol.168.11.5629
10.4049/jimmunol.168.11.5629 · External reference
Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease
10.1111/j.1399-3038.2008.00779.x · 2009 · External reference
Matrix metalloproteases as a pharmacological target in cardiovascular diseases
2015 · External reference
Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasakidisease
10.1097/inf.0b013e31825ba6b3 · 2012 · External reference
The treatment of Kawasaki syndrome with intravenous gamma globulin
10.1056/nejm198608073150601 · 1986 · External reference
10.1002/jcb.28571
10.1002/jcb.28571 · External reference
Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki disease
10.1371/journal.pone.0197858 · 2018 · External reference
iPhos: a toolkit to streamline the alkaline phosphatase-assisted comprehensive LC-MS phosphoproteome investigation
2014 · External reference
